Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only


The availability of the assay on the fully automated random-access LUMIPULSE G analyzers provides researchers access to convenient, accurate, and robust measurement of pTau 217 in CSF, in addition to blood. Already widely available for routine use in neurological disease testing worldwide, these analyzers meet all necessary quality, throughput, and regulatory requirements.



Source link

  • Related Posts

    Rob Shaw: Ottawa tightens health funding at the exact wrong moment for B.C.

    Provincial finance minister warns of a 2028 cliff after Carney’s budget reduced Canada Health Transfer growth rate Source link

    Live Updates: Warsh Nomination Advances Through Senate Committee

    To Kevin M. Warsh, the Federal Reserve’s more than $6 trillion portfolio of government bonds and mortgage-backed securities is emblematic of everything that has gone wrong at the institution he…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    5 Aerodynamic Advantages Of The B-2 Spirit For Long-Range Stealth Missions

    5 Aerodynamic Advantages Of The B-2 Spirit For Long-Range Stealth Missions

    Rob Shaw: Ottawa tightens health funding at the exact wrong moment for B.C.

    Rob Shaw: Ottawa tightens health funding at the exact wrong moment for B.C.

    Hockey fans in Buffalo step in, sing ‘O Canada’ after singer’s mic failure – National

    Hockey fans in Buffalo step in, sing ‘O Canada’ after singer’s mic failure – National

    Inside Tehran’s main airport as more flights take off during ceasefire | Aviation

    Inside Tehran’s main airport as more flights take off during ceasefire | Aviation

    TSA PreCheck offers discount to younger travelers. Here’s what to know.

    TSA PreCheck offers discount to younger travelers. Here’s what to know.

    Live Updates: Warsh Nomination Advances Through Senate Committee

    Live Updates: Warsh Nomination Advances Through Senate Committee